Sebastian Schöfer has joined Merck Ventures, the corporate venture capital arm of Germany-based pharmaceutical firm Merck Group, as a senior associate.
Schöfer moved from High-Tech Gründerfonds (HTGF), the VC fund backed by a range of corporate limited partners. He had been an investment manager at the fund since 2014 after stints at solar system provider Azuri Technologies and technology transfer fund Imperial Innovations.
Merck Ventures has offices in the Netherlands, the US and Israel, and had its fund size doubled from €150m to €300m ($320m at current exchange rates) in June 2016.
– Photo of Sebastian Schöfer courtesy of Merck Ventures